Related Experiment Video
Updated: Dec 31, 2025

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
[Names and indications of antibodies facing regulations and pharmaceutical company practices]
Laura Foucault-Fruchard1, Hervé Watier2, Daniel Antier1
1CHRU de Tours, 37000 Tours, France - UMR 1253, iBrain, Université de Tours, Inserm, 37000 Tours, France.
Abstract:
The names and therapeutic indications of monoclonal antibodies must comply with current regulations, which does not prevent the development of commercial strategies around trade names. Some of these practices are based on territorial or legal considerations while others are motivated by real medical concerns. Finally, some of these have a significant financial impact on the community.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Nomenclature
Cross-reactivity
Drug Regulation
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

